A Clinical Study on Cefdinir in Pediatrics

Yoshitake Satoh; Satoshi Iwata; Hironobu Akita; Keisuke Sunakawa

doi:10.11553/antibiotics1968b.43.1796

A Clinical Study on Cefdinir in Pediatrics

Yoshitake Satoh, Satoshi Iwata, Hironobu Akita, Keisuke Sunakawa

Department of Infectious Diseases

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Clinical evaluations of cefdinir (CFDN, FK482) were carried out. The obtained results are summarized as follows. 1. Clinical responses to CFDN of 43 patients with pediatric infections were excellent in 23, good in 15, fair in 4 and poor in 1. The overall efficacy rate was 88%. 2. Bacteriologically, the eradication rate for 34 isolates presumedto be pathogens was evaluated and the eradication rate was 85.3%. 3. Side effects observed were diarrhea in 4 of 48 patients. The incidence was 8.3%. Abnormal laboratory findings were an elevation of GOT, an elevation of eosinophile and an increase in platelet counts. The results suggested that CFDN might be a very useful and safe drug for the treatment of pediatric infections.

Original language	English
Pages (from-to)	1796-1805
Number of pages	10
Journal	the japanese journal of antibiotics
Volume	43
Issue number	10
DOIs	https://doi.org/10.11553/antibiotics1968b.43.1796
Publication status	Published - 1990

ASJC Scopus subject areas

Microbiology (medical)
Pharmacology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.11553/antibiotics1968b.43.1796

Cite this

@article{b09c52c07fa944468a35f9d05dd9573e,

title = "A Clinical Study on Cefdinir in Pediatrics",

abstract = "Clinical evaluations of cefdinir (CFDN, FK482) were carried out. The obtained results are summarized as follows. 1. Clinical responses to CFDN of 43 patients with pediatric infections were excellent in 23, good in 15, fair in 4 and poor in 1. The overall efficacy rate was 88%. 2. Bacteriologically, the eradication rate for 34 isolates presumedto be pathogens was evaluated and the eradication rate was 85.3%. 3. Side effects observed were diarrhea in 4 of 48 patients. The incidence was 8.3%. Abnormal laboratory findings were an elevation of GOT, an elevation of eosinophile and an increase in platelet counts. The results suggested that CFDN might be a very useful and safe drug for the treatment of pediatric infections.",

author = "Yoshitake Satoh and Satoshi Iwata and Hironobu Akita and Keisuke Sunakawa",

year = "1990",

doi = "10.11553/antibiotics1968b.43.1796",

language = "English",

volume = "43",

pages = "1796--1805",

journal = "the japanese journal of antibiotics",

issn = "0368-2781",

publisher = "Japan Antibiotics Research Association",

number = "10",

}

TY - JOUR

T1 - A Clinical Study on Cefdinir in Pediatrics

AU - Satoh, Yoshitake

AU - Iwata, Satoshi

AU - Akita, Hironobu

AU - Sunakawa, Keisuke

PY - 1990

Y1 - 1990

N2 - Clinical evaluations of cefdinir (CFDN, FK482) were carried out. The obtained results are summarized as follows. 1. Clinical responses to CFDN of 43 patients with pediatric infections were excellent in 23, good in 15, fair in 4 and poor in 1. The overall efficacy rate was 88%. 2. Bacteriologically, the eradication rate for 34 isolates presumedto be pathogens was evaluated and the eradication rate was 85.3%. 3. Side effects observed were diarrhea in 4 of 48 patients. The incidence was 8.3%. Abnormal laboratory findings were an elevation of GOT, an elevation of eosinophile and an increase in platelet counts. The results suggested that CFDN might be a very useful and safe drug for the treatment of pediatric infections.

AB - Clinical evaluations of cefdinir (CFDN, FK482) were carried out. The obtained results are summarized as follows. 1. Clinical responses to CFDN of 43 patients with pediatric infections were excellent in 23, good in 15, fair in 4 and poor in 1. The overall efficacy rate was 88%. 2. Bacteriologically, the eradication rate for 34 isolates presumedto be pathogens was evaluated and the eradication rate was 85.3%. 3. Side effects observed were diarrhea in 4 of 48 patients. The incidence was 8.3%. Abnormal laboratory findings were an elevation of GOT, an elevation of eosinophile and an increase in platelet counts. The results suggested that CFDN might be a very useful and safe drug for the treatment of pediatric infections.

UR - http://www.scopus.com/inward/record.url?scp=0025244206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025244206&partnerID=8YFLogxK

U2 - 10.11553/antibiotics1968b.43.1796

DO - 10.11553/antibiotics1968b.43.1796

M3 - Article

C2 - 2086817

AN - SCOPUS:0025244206

SN - 0368-2781

VL - 43

SP - 1796

EP - 1805

JO - the japanese journal of antibiotics

JF - the japanese journal of antibiotics

IS - 10

ER -

A Clinical Study on Cefdinir in Pediatrics

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this